Apeloa Pharmaceutical Co Ltd Sustainability Reports
Apeloa Pharmaceutical Co., Ltd. researches, develops, manufactures, and markets active pharmaceutical ingredients (APIs), intermediates, finished dosage forms (FDFs), and contract development and manufacturing organization (CDMO) services. Its product lines encompass anti-infective, cardiovascular, antiviral, and anti-tumor therapeutic segments.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001SJWK96
5 reports from 2024 to 2025
- Apeloa Pharmaceutical Co Ltd 2025 Annual Report
- Apeloa Pharmaceutical Co Ltd 2025 Environmental, Social and Corporate Governance (ESG) Report
- Apeloa Pharmaceutical Co Ltd 2025 Environmental, Social, and Corporate Governance (ESG) Report
- Apeloa Pharmaceutical Co Ltd 2024 Environmental, Social and Governance (ESG) Report
- Apeloa Pharmaceutical Co Ltd 2024 Environmental, Social, and Corporate Governance (ESG) Report
